Paiteling treatment of cervical cervical high-risk HPV infection outcome
10.3969/j.issn.1005-1678.2017.05.040
- VernacularTitle:派特灵宫颈治疗对宫颈高危型人乳头瘤病毒感染转归的影响
- Author:
Huiqing GU
;
Xuefeng CHEN
;
Yaqin LUO
- Keywords:
paiteling;
cervical;
high-risk HPV infection
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(5):122-124
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the treatment effect on cervical Paiteling cervical high-risk human papiloma virus(HPV) infection outcome.MethodsRandomly selected from our hospital during January 2014 to January 2016 in 120 cases of cervical high-risk HPV infection patients as the research object, of which 40 cases were treated with Paiteling treatment (Paiteling group), 40 patients were treated with foscarnet sodium (foscarnet sodium group).Another 40 patients without intervention (control group).The outcome of HPV infection in three groups was compared.ResultsPatients with negative rate of special spirit (87.50%) and foscarnet sodium group (55.00%) and control group (50.00%) was statistically significant(P<0.05), and the special spirit Group continued the positive rate (2.50%) was significantly lower than the control group (42.50%) and foscarnet sodium group (37.50%).However, there was no significant difference between the groups in the rate of improvement and the incidence of new infections.There was no significant difference between the control group and the positive rate (50.00%) in the control group (42.50%) compared with that in the control group.ConclusionPaiteling treatment of clinical effect of cervical high-risk HPV infection, can effectively improve the symptoms of HPV infection, which can shorten the HPV clearance time, has positive clinical significance.
